Impact Of Foodborne Diseases On The Gastrointestinal Pathogen Testing Market: Key Factor Driving The Growth In The Gastrointestinal Pathogen Testing Market

The Gastrointestinal Pathogen Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Gastrointestinal Pathogen Testing Market Size During the Forecast Period?
The gastrointestinal pathogen testing market has seen steady growth in recent years. It will expand from $4.05 billion in 2024 to $4.24 billion in 2025, at a CAGR of 4.6%. This growth can be attributed to the increased prevalence of gastrointestinal infections, greater awareness of foodborne illnesses, and regulatory initiatives for food safety.

The gastrointestinal pathogen testing market is set to see steady growth, reaching $5.01 billion by 2029 at a CAGR of 4.3%. The growth is attributed to the rising prevalence of gastrointestinal infections worldwide, increased awareness around early detection and treatment, expanding healthcare infrastructure in emerging economies, the rising demand for point-of-care testing, and ongoing R&D efforts. Major trends include rapid testing techniques, growing use of molecular diagnostics, increased adoption of point-of-care testing in non-traditional settings, automation advancements for streamlined testing, new biomarkers for improved pathogen detection, and the integration of AI and machine learning in diagnostics.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15571

What Are the High-Growth Segments in the Gastrointestinal Pathogen Testing Market?
The gastrointestinal pathogen testing market covered in this report is segmented -

1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

What Key Drivers Are Expected to Influence Future Gastrointestinal Pathogen Testing Market Growth?
The surge in foodborne illness cases is forecasted to support the gastrointestinal pathogen testing market. Foodborne diseases result from consuming food contaminated with harmful microbes, toxins, or chemicals. Common diseases include listeriosis, gastroenteritis, taeniasis, and trichinosis. Factors like evolving food production systems, insufficient food safety practices, and climate change contribute to rising cases. Gastrointestinal testing helps detect specific pathogens responsible for such illnesses, guiding treatment, outbreak tracking, and preventive strategies. For example, in February 2024, the UK Health Security Agency reported that listeriosis cases in England and Wales rose from 160 in 2021 to 167 in 2022. Thus, the increase in foodborne diseases is stimulating the gastrointestinal pathogen testing market.

Which Companies Hold the Largest Share Across Different Gastrointestinal Pathogen Testing Market Segments?
Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

What Gastrointestinal Pathogen Testing Market Trends Are Gaining Traction Across Different Segments?
Leading firms in the gastrointestinal pathogen testing market are concentrating on developing innovative solutions, such as metagenomic diagnostic tests, to augment the precision, rapidity, and breadth of gastrointestinal pathogen detection. Metagenomic diagnostic tests represent a cutting-edge mechanism for inspecting the genetic data of microorganisms in samples like stool or blood. For example, Microba Life Sciences, a biotech firm based in Australia, launched the MetaPanel in April 2024. This metagenomic diagnostic test is engineered to pinpoint a vast array of gastrointestinal pathogens with unprecedented accuracy. The MetaPanel can identify 175 pathogen targets in a single test, providing a holistic solution for health practitioners to diagnose a broad spectrum of both common and elusive infections. Using next-generation sequencing (NGS) technology, it can examine an extensive variety of genetic data in a stool sample. This facilitates the identification of a multitude of possible pathogens, including ones traditionally not tested for in standard gastrointestinal panels.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

What Are the Emerging Geographies for The Gastrointestinal Pathogen Testing Market Growth?
North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastrointestinal Pathogen Testing Market?
2. What is the CAGR expected in the Gastrointestinal Pathogen Testing Market?
3. What Are the Key Innovations Transforming the Gastrointestinal Pathogen Testing Industry?
4. Which Region Is Leading the Gastrointestinal Pathogen Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.